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Since summer 2010, numerous cases of Rabbit Haemorrhagic Disease (RHD) have been reported in north-western
France both in rabbitries, affecting RHD-vaccinated rabbits, and in wild populations. We demonstrate that the
aetiological agent was a lagovirus phylogenetically distinct from other lagoviruses and which presents a unique
antigenic profile. Experimental results show that the disease differs from RHD in terms of disease duration, mortality
rates, higher occurrence of subacute/chronic forms and that partial cross-protection occurs between RHDV and the
new RHDV variant, designated RHDV2. These data support the hypothesis that RHDV2 is a new member of the
Lagovirus genus. A molecular epidemiology study detected RHDV2 in France a few months before the first
recorded cases and revealed that one year after its discovery it had spread throughout the country and had almost
replaced RHDV strains. RHDV2 was detected in continental Italy in June 2011, then four months later in Sardinia.Introduction
Rabbit Haemorrhagic Disease (RHD) is a highly infec-
tious and often fatal viral disease of the European rabbit
Oryctolagus cuniculus. It was first described in China in
1984 [1] and is currently enzootic in wild populations in
Europe but also in Australia and New Zealand where it
was introduced as a biocontrol agent [2]. Periodic cases
have been reported in domestic rabbits in other parts of
the world including the Americas. When it emerged,
RHD strongly affected wild populations and was respon-
sible for great economic losses in the rabbit industry
[3,4]. The development of efficient commercial vaccines
that totally protect against the disease has enabled its
control in rabbitries [5].
Susceptibility to the disease begins in the 5-6th week of
life of rabbits and steadily increases up to the 8-9th week
when they become fully susceptible. RHD is mainly
characterised by a peracute/acute course with high
mortality, up to 80–100%, in 48 to 96 h [6]. During* Correspondence: ghislaine.legall-recule@anses.fr
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distribution, and reproduction in any mediuman outbreak, 5 to 10% of rabbits may show subacute/
chronic evolution of the disease. They can die 1 or
2 weeks later, probably due to liver dysfunction, or re-
cover and seroconvert with very high antibody titres [7].
Typical post-mortem lesions include hepatic necrosis
and splenomegaly. In a variety of organs and tissues,
congestion and haemorrhages resulting from a dissemi-
nated intravascular coagulation syndrome are common.
The trachea is often hyperaemic and contains frothy,
bloodstained mucus [6].
The aetiological agent of the disease, the Rabbit
Haemorrhagic Disease Virus (RHDV), is a non-en-
veloped single-stranded positive-sense RNA virus [8-11]
belonging to the genus Lagovirus of the family Cali-
civiridae [12]. Only one serotype is known, including the
antigenic variant named RHDVa, which was identified
simultaneously in 1996–1997 in Germany and Italy
[13,14], before spreading throughout the world. Al-
though RHDV is an RNA virus, it shows low genetic
variability [15-18]. Nevertheless, different studies have
pointed out that RHDV is distributed into several phylo-
genetically distinct groups. French RHDV isolates have
been assigned into 5 genetic groups (G1 to G5) follow-
ing a temporal distribution [16]. More recently, RHDV
was shown to cluster into 3 major groups, one of whichCentral Ltd. This is an Open Access article distributed under the terms of the
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[18,19]. RHDVa forms a distinct genetic group (G6
according to [16], Group 1 or Clade D according to [18]
or [19]) but cross-protection is almost complete between
RHDV and RHDVa.
Since the 1990’s, different non-pathogenic or moder-
ately pathogenic rabbit lagoviruses genetically related to
but relatively distant from RHDV have been described,
highlighting the extent of diversity within the lagoviruses
[20-25]. The first non-pathogenic lagovirus known as
the rabbit calicivirus (RCV) was identified in the small
intestines of healthy domestic rabbits in Italy in 1996
[20]. Afterwards, several distinct non-pathogenic la-
goviruses were identified in Europe [22,23,25] and
Australia [21] in domestic or/and wild rabbits. Experi-
mental studies have proven the existence of a gradient of
cross-protection between these non-pathogenic strains
and RHDV, from non-protective (strain 06–11) [25] and
partially protective (RCV-A1) [26] to fully protective
(RCV) [20]. Recently, a possible moderately pathogenic
rabbit lagovirus (Michigan rabbit calicivirus, MRCV)
was characterised following mortalities in a rabbitry in
2001 in the USA [24]. Its pathogenicity remains doubtful
since it was isolated in dead rabbits showing clinical
signs suggesting RHD but for which experimental infec-
tions failed to reproduce the disease.
In August 2010, one atypical case of RHD was
reported in a rabbitry in northern France in which 25%
of RHDV-vaccinated does died, as well as numerous
non-vaccinated fattening rabbits [27]. A few similar
cases were then reported, but their number markedly in-
creased in north-western France as of October 2010.
During the same period, several outbreaks were reported
in wild rabbit populations in the same area. Macroscopic
and microscopic examinations of organs revealed typical
RHD lesions [27]. Samples collected in mid-October in
north-western France from domestic and wild rabbits re-
vealed the presence of a virus genetically related to but
distant from RHDV and RHDVa isolates. Its phylogen-
etic relationships with known pathogenic and non-
pathogenic rabbit lagoviruses established from a partial
nucleotide sequence of the capsid protein VP60 (354 bp
long) suggested that it was a new genetic group [27].
The new RHDV variant, hereafter referred to as RHDV2,
was subsequently identified for the first time in Italy in
one industrial farm in the Udine province (north-eastern
Italy) in June 2011 [28].
In this work, the phylogenetic relationships of RHDV2
to other rabbit lagoviruses were confirmed by describing
the complete sequence of the capsid protein gene. Its
antigenic properties were determined and its pathogen-
icity was investigated in experimental studies. In
addition, a molecular epidemiological survey of RHDV
isolates collected in France between 2009 and 2011 wasconducted to determine whether RHDV2 was present
before its first detection and to describe its spread
throughout France. The presence of cases of RHDV2 in
Italy was also sought.Materials and methods
Biological samples
Dead rabbits were collected from rabbitries affected by
RHD to characterise the viruses involved in these out-
breaks. New Zealand White RHDV-vaccinated does
(case 10–05), non-vaccinated fattening rabbits (cases
10–07, 10–28 and 10–32), and young rabbits just before
weaning (4-week-olds, case 10–08) were collected in 5
industrial rabbitries located in north-western France be-
tween September and November 2010. In addition, sam-
ples were collected in two epidemiologically related
farms in the Udine province (north-eastern Italy) in June
and July 2011 (case Ud11). In all cases, post-mortem ex-
aminations of dead rabbits revealed typical RHD lesions.
A molecular epidemiological study was carried out to
monitor the spread of RHDV2 in France. We performed
RT-PCR and genotyping analyses to describe the isolates
involved in RHD outbreaks starting in 2009. For
this purpose we analysed liver specimens of 191 wild
rabbits whose deaths were attributed to RHD, collected
throughout France between January 2009 and December
2011 by the SAGIR network (French Wildlife Health
Surveillance Network, [29]). Some of the analysed sam-
ples belong to the same epizootic. The presence in these
samples of RHDV had previously been confirmed by the
Anjou Laboratory (Angers, France) using an RHDV
ELISA test [30]. In addition, we analysed liver samples of
domestic rabbits that died from RHD: one archived
RHD case (case 10–01) that occurred in April 2010 in a
rabbitry in north-western France and 70 rabbits reared
in 63 industrial rabbitries that died of RHD between
October 2010 and December 2011.
Regarding the presence of RHDV2 in Italy, information
was obtained as part of the existing epidemiological sur-
veillance plan for RHD, further implemented after the
identification of the first case of RHDV2 in June 2011.
Thus, 74 samples were collected between November
2009 and October 2011 in domestic and wild rabbits
from different parts of Italy. Post-mortem analyses of
liver samples were carried out using a diagnostic ELISA
test [5] to determine whether RHDV was the cause of the
observed mortalities. The antigenic profile of each RHDV
isolate was then identified with a sandwich ELISA (de-
scribed in the chapter below) in order to determine its
group (RHDV, RHDVa or RHDV2). In addition, a few
rabbit samples collected between October 2011 and early
2012 in Sardinia and the Trentino region (northern Italy)
where RHDV outbreaks occurred were characterised.
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The antigenic profile of the RHDV2 strains 10–28, 10–
32 and Ud11, the RHDV reference strain Bs89 (X87607),
the RHDVa reference strain Pv97 (EU250330), and the
EBHSV reference strain Bs89 (X98002) were compared
using sandwich ELISA with a panel of 26 monoclonal
antibodies (MAbs) produced for RHDV (16 MAbs) or
EBHSV (10 MAbs). On the basis of their reactivity, they
were divided into 4 subsets: i) 2A10, 1H3 and 1H8 are
specific to RHDV and recognise at least two independent
epitopes [31], ii) 3B12, 3D4, 3D6, 5D11 and 2E1 are spe-
cific to RHDVa and recognise at least 3 independent epi-
topes [32], iii) 2B4, 2G3, 1F10, 6H6, 3H2, 6D6, 6 F9 and
3H6 react with both RHDV and RHDVa and recognise
at least 6 independent epitopes. The last 3MAbs (6D6,
6F9 and 3H6), although produced for RHDV, also cross-
react with EBHSV indicating that the corresponding epi-
topes are common to these lagoviruses [31], iv) 2B2,
1C5, 3D6, 4E3, 1F8, 5 F5, 1G8, 1H1, 1H12 and 4H4 are
specific to EBHSV.
For the sandwich ELISA, convalescent anti-RHDV
rabbit sera were adsorbed to a Nunc Maxisorp ELISA
plate at a dilution of 1/5000 in standard carbonate buf-
fer. Ten percent liver homogenate RHDV positive was
pre-titrated in ELISA [5] and used at a dilution that gave
an OD492 value in the range of 1.2-1.5. MAbs were used
in the range of 20–200 ng/mL depending on the reactiv-
ity with the homologous virus. Finally, a rabbit IgG anti
mouse IgG labelled with HRP was used to detect binding
of the MAbs to the viruses. In order to control the re-
activity of MAbs anti-EBHSV, a sandwich ELISA using a
hare serum anti-EBHSV adsorbed to the solid phase and
the reference strain EBHSV BS89 were additionally
employed.
Haemagglutination (HA) test
An HA test was performed for assessing the haemag-
glutinating properties of RHDV2 towards human type
“O” erythrocytes in comparison with reference RHDV
and RHDVa strains, and for estimating the viral load of
the inocula used in the experimental studies. Samples
containing the strains 10–28, 10–32 and Ud11 were
tested using the classical protocol with human group
“O” red blood cells (RBC) [5]. Briefly, the HA test was
performed at 4 °C with 10% liver homogenate in PBS
pH 7.4 and washed RBC diluted to 1% in PBS pH 7.2.
RT-PCR and sequence analysis
The VP60 gene sequences of the 7 RHDV2 strains
isolated from dead rabbits collected from rabbitries in
France and Italy (cases 10–01, 10–05, 10–07, 10–08,
10–28, 10–32, Ud11) were determined. RNA was
extracted from 100 μL of liver exudate using the RNeasy
Mini kit (QIAGEN) or from 10 μL of liver homogenisedin PBS (100 mg/mL) with TRIzol® Reagent (Invitrogen).
They were reverse transcribed using oligo-dT (Invi-
trogen) as a primer and Superscript™ II Reverse Trans-
criptase (Invitrogen). The capsid protein VP60 gene
sequences of the French viruses were obtained following
full-length gene PCR amplification using the primers
“12U” (5’-GTCGTCTCGGTAGTACCTG-3’) and “15 L”
(5’-ATCAAGCACTGGACTCGCC-3’). The amplified
PCR products (2116 bp) were visualised by electrophor-
esis on agarose gel and purified prior to sequencing. The
DNA sequence was determined twice in both directions
by the dye terminator method (Applera Applied Bio-
systems) using the PCR primers “12U” and “15 L” as
well as several primers designed in the inner region of
the DNA template (primer sequences available upon
request). The Italian Ud11 VP60 gene sequence was
obtained following 3 overlapping PCR (PCR1: 5225-F 5’-
GCTACGATGCTGCTAGGAAGATACT-3’ and RHDV-
R 5’-AACCCTCCAGGTACTGGTTG-3; PCR2: RHDV-F
5’-CCTGTTACCATCACCATGCC -3’ and 6694-R 5’-
CGAACATGATGGGTGTGTTC-3’; PCR3: 9510-F 5’-
ACATACACACCTCAACCAGA-3’ and 109-R 5’-CGCC
GGCGCCTGCAAGTCCCAATCC-3’). The amplified tem-
plates were purified and sequenced as mentioned above
using the PCR primers. The deduced amino acid sequences
of the VP60 genes were obtained using the “EMBOSS
Transeq” software available on the EMBL-EBI website.
Nucleotide or amino acid sequence alignments were
generated by the CLUSTAL W method [33] using the
NPS@) software [34] from the PBIL website.
For the molecular epidemiological survey of French
RHDV isolates, we used the PCR primers “14U1” (5’-
GAATGTGCTTGAGTTYTGGTA) and “RVP60-L1” (5’-
CAAGTCCCAGTCCRATRAA) to amplify 794 pb located
in the C-terminal of the gene encoding VP60. These amp-
lified templates were subsequently sequenced using the
PCR primers. In order to genotype the isolates, the se-
quences were aligned and compared with lagovirus se-
quences representative of the different RHDV genetic
groups [16,18,19], the non-pathogenic lagoviruses, and
RHDV2.
Phylogenetic analyses
Phylogenetic relationships were inferred using the 7
French and Italian RHDV2 VP60 gene sequences ob-
tained from this study and the complete rabbit lagovirus
VP60 gene sequences available in databases. The RHDV
strain Hartmannsdorf (Y15426) for which evidence of
recombination in the capsid region of the genome was
shown [18,35] was excluded as well as identical sequen-
ces corresponding to the same viral strain but with dif-
ferent accession numbers. Thus, 46 RHDV, 34 RHDVa,
the non-pathogenic RCV and 06–11 strains, 36 non-
pathogenic RCV-A1 isolates and the possibly moderately
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RHDV2. An additional file shows the sequence names
and their accession numbers (see Additional file 1). The
sequence of the French reference European Brown Hare
Syndrome Virus (EBHSV) strain EBHSV-GD (Z69620)
was used as an outgroup to root the trees. Different
phylogenetic analyses were conducted using MEGA soft-
ware version 5 [36]. Phenetic (Neighbor-joining (NJ) and
Minimum Evolution (ME) methods) and Maximum
Likelihood (ML) analyses were implemented with the
pairwise deletion option and based on the Kimura 2-
parameter model including transition and translation
substitutions. For the cladistic analysis, the Maximum
Parsimony (MP) method was used and the pairwise dele-
tion option was selected. For all the methods, the codon
positions included were 1st + 2nd + 3rd. For the ME, ML
and MP methods, the search for the trees was im-
plemented with the close-neighbor-interchange algo-
rithm. Reliability of the trees was assessed by bootstrap
with 1000 replicates, except for the ML method (500
replicates). Pairwise nucleotide distance comparisons
based on the p-distance model were conducted using
MEGA5.
Recombination analysis
To determine whether recombination events occurred
within the VP60 gene of RHDV2, the capsid gene se-
quences available in databases and the RHDV2 sequence
were screened using RDP4 Beta 4.16 software [37].
Experimental infections
In order to study the pathogenicity of RHDV2 and the
induced pathological lesions, several experimental stud-
ies were performed under negative pressure in BSL2
(France) and BL3 (Italy) experimental facilities. In
France, the animal experiments were carried out in
accordance with the guidelines of the European Com-
munity Council on Animal Care (86/609/CEE) and
approved by the ethical committee of the Veterinary Col-
lege Scientific Council. In Italy, they were performed in
compliance with the provisions of national and European
laws (DM 2894/95 and DLgs 116/92, receipt of 86/
609/CEE).
RHDV seronegative rabbits aged ten weeks and older
were used. Their seronegativity was checked with a
VP60-RHDV ELISA based on the detection of a baculo-
virus expressed capsid protein, as described in [25] or
with a competition ELISA (cELISA) used for the ser-
ology of RHDV classical strains [38]. The rabbits were
New Zealand rabbits coming from commercial suppliers
and unselected rabbits coming from a rural unit. De-
pending on the experimental batch, the rabbits were in-
oculated by the intramuscular, oral, or intravenous route
with 4 different inocula made up of supernatant (1 mL)of homogenised dead rabbit liver samples collected from
3 French rabbitries (strains 10–07, 10–28, and 10–32)
and from the Italian farm (strain Ud11). The viral load
of the different livers used for the infections was esti-
mated using the HA test and gave titres of between 1/
5120 and 1/10 240. The inocula were prepared accor-
ding to approximately the same protocol (1/10-1/20
dilution of the supernatant of at least 10% w/v ho-
mogenised liver in PBS). In two studies (A and G), one
group of rabbits was challenged with a standardised
inoculation of 103 LD50 of RHDV reference strain
(V/RHD/4) isolated in 1988 in France [39] as a control.
In addition, in studies F, I, and L, 18 seropositive sur-
vivor rabbits were challenged one month later with ap-
proximately 2.103 LD50 of the Italian reference RHDV
strain BS89 [40] to estimate the level of protection in-
duced by the RHDV2 strain.
Daily observations for morbidity (asthenia, anorexia,
respiratory and nervous signs) and mortality were
performed. Dead animals, as well as animals surviving at
the end of the experimental study and which were
anaesthetised before being killed, were examined for
macroscopic lesions. Liver samples were collected to
confirm the cause of death by RT-PCR analyses. Except
for the A, B, and G experiments, blood samples were
collected from survivor rabbits two weeks post ino-
culation to check whether the rabbits seroconverted.
Antibody titres were measured with the previously men-
tioned cELISA.
Statistical analyses
The effects of viral strains on mortality rates were stu-
died using χ2 tests.
Nucleotide sequence accession numbers
Nucleotide sequences of RHDV2 strains are available in
databases under the EMBL/GenBank accession numbers
FR819781 (10–05), HE800529 to HE800532 (10–01,
10–07, 10–28 and 10–32, respectively), HE819400 (10–08)
and JQ929052 (Ud11).
Results
Sequence analysis of the capsid protein
The 7 RHDV2 VP60 gene sequences are 1740 nucleo-
tides long (579 amino acids long) and are closely related
to each other (1.3% nucleotide difference on average).
The average nucleotide identity between RHDV2 and
RHDV-RHDVa is 82.4%. The RHDV2 share 82% identity
on average with RCV, 06–11 and MRCV strains, and
80.6% identity with RCV-A1 isolates. Nucleotide identity
is 70.4% with EBHSV, showing that RHDV2 is closer to
rabbit lagoviruses. Amino acid similarity between the 7
RHDV2 strains is 99.3%, whereas average similarity is
about 89.2% with the RHDV-RHDVa, RCV, 06–11, and
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acid similarity is 76.7% with EBHSV.
The consensus sequence of the 7 RHDV2 deduced
protein sequences was aligned with the consensus se-
quences of the RHDV sequences available in databases
and belonging to the different genetic groups (G1 to G6)
identified by Le Gall-Reculé et al. [16]. The genetic
group G5 corresponds to the main genetic group that
was circulating in France until the emergence of
RHDV2. The MRCV, RCV, and 06–11 sequences, and
the consensus sequence of RCV-A1 sequences were also
included (Figure 1). Most of the substitutions are located
in the most variable part of the capsid protein, the
C-terminal region, which constitutes the protrusion (P)
domain of the particle [41-43] and contains the main
antigenic regions [31]. Twenty-five amino acid substitu-
tions are only shared with some non-pathogenic viruses,
sometimes including the MRCV, and 16 substitutions
are shared by no rabbit lagoviruses (Figure 1). When we
compared the RHDV2 sequence within the 7 regions of
the P domain that show the highest degree of genetic
variation (regions V1 to V7 [43]), similarities decreased
to 65.3%, 63.2%, 60%, 59.2% and 53%, between RCV-A1,
RCV, RHDV, MRCV and 06–11, respectively (Figure 1).
These data emphasised the differences between the
viruses.
The analyses failed to detect any recombination event
with another lagovirus within the VP60 gene.
Genetic relationships
Phylogenetic analyses based on the VP60 gene nucleo-
tide sequences of the 7 studied RHDV2 strains and
the available rabbit lagoviruses in the databases gave
similar results irrespective of the method used. We show
the tree generated by the Neighbor-Joining method
(Figure 2). The results revealed that the rabbit lagovi-
ruses were clustered into four highly supported phylo-
genetic groups, (i) a first group including the pathogenic
RHDV and RHDVa isolates, (ii) a second group inclu-
ding the MRCV, 06–11, and Ashington strains, (iii) a
third group including the RHDV2 strains, and (iv) a
fourth group including the RCV-A1 isolates. The RCV
forms a separate branch without a significant bootstrap
value but regardless of the phylogenetic analysis used, it
always clusters into the large group consisting of the first
and the second genetic groups. The new phylogenetic
group formed by RHDV2 was more closely related to
RHDV and RCV-like viruses than to the independent
RCV-A1 genetic group.
Antigenic characterisation and HA properties
Using ELISA, no specific MAb belonging to the subsets
i and ii reacted with RHDV2; nor did MAbs 2B4 and
2G3 of the subset iii (Table 1). In addition, MAbs 1F10and 6H6, belonging to the cross-reactive subset iii,
showed a consistent decrease in reactivity with RHDV2
(about 85% and 50%, respectively). As a consequence,
the reactivity with the available MAbs might suggest that
RHDV2 is antigenically close to EBHSV. However, the
10 specific EBHSV MAbs did not react with RHDV2, or
with RHDV or RHDVa. These results show that, in
agreement with the above genetic data on the 7 regions
that show the highest degree of genetic variation, the
antigenic surface of RHDV2 was very different from that
of both RHDV and RHDVa. The finding that most of the
anti-RHDV MAbs not recognising RHDV2 do not
recognise EBHSV either, suggests that the degree of
antigenic difference between RHDV2 and the other
RHDV was similar to that between EBHSV and the other
RHDV.
The 3 RHDV2 tested (10–28, 10–32 and Ud11)
resulted in positive HA tests with titres ranging from 1/
1280 to 1/20 480 according to the livers tested, i.e. simi-
lar to those usually found with most of the RHDV or
RHDVa isolates. These results show that RHDV2 agglu-
tinates human RBC of type “O” efficiently and confirmed
that the HA test, which constitutes a routine diagnostic
method still used in some veterinarian laboratories, can
identify the presence of RHDV2 in infected samples.
Experimental infections
The different experimental studies performed to de-
termine the pathogenicity of RHDV2 confirmed its vi-
rulence regardless of the inoculation route (Table 2).
Mortalities occurred later and over a longer period than
with both classical RHDV and RHDVa: 3–9 days post-
inoculation and lasting 5 days, instead of 2–6 days post-
inoculation and lasting 3–4 days as generally observed
with classical RHD. A few animals, especially in experi-
ments that showed a higher level of mortality, presented
an acute course of the disease and died within 3–4 days.
Rabbits that developed a subacute/chronic course were
more frequent than for classical RHD. Thus, the ob-
served macroscopic lesions were typical of RHD but
with a more frequent occurrence of the severe liver de-
generation and discoloration, splenomegaly and jaundice
that characterise the subacute/chronic form of RHD [6].
Rabbits that survived the infection did not show any
clinical signs and were fed regularly.
The serological analyses showed that the survivors
were seropositive, demonstrating that all the rabbits had
been successfully infected. However, the observed mor-
tality rates were lower than with classical RHD and
seemed highly variable (Table 2). The similarity between
RHDV2 infected livers and RHDV or RHDVa infected
livers with regard to HA titres showed that there was a
similar amount of virus in the livers of dead rabbits, re-
gardless of the virus. In addition, by using an almost
10        20        30        40        50        60 70        80        90       100
|         |         |         |         |         | |         |         |         |
RHDV-G1        MEGKARTAPQGEAAGTATTASVPGTTTDGMDPGVVATTSVVTAENSSASIATAGIGGPPQQVDQQETWRTNFYYNDVFTWSVADAPGSILYTVQHSPQNN
RHDV-G2 ------A---------------------------------I-----------------------------------------------------------
RHDV-G3/G4 -----------------------------L----------------------------------------------------------------------
RHDV-G5        -----------------------------L----------------------------------------------------------------------
RHDVa-G6 ------------------------------------A------------V--------------------------------------------------
RCV            ------IT----------------------------------T--A-T-V--------------------------------------------------
06-11          ------IT----------------------------------T--A-T----------------------------------------------------
MRCV           ------AT----T---------------------M-------T--A---M--------------------------------T-----------------
RHDV2      ------A-----T-----------------------------T--A-T---------------------------------------N------------
RCVA-1         -------T---DT--------------------------------A-T-V--------------------------------T---------A-------
110       120 130       140       150       160       170       180 190       200
|         | |         |         |         |         |         | |         |
RHDV-G1        PFTAVLSQMYAGWAGGMQFRFIVAGSGVFGGRLVAAVIPPGIEIGPGLEVRQFPHVVIDARSLEPVTITMPDLRPNMYHPTGDPGLVPTLVLSVYNNLIN
RHDV-G2 ----------------------------------------------------------------------------------------------------
RHDV-G3/G4     ----------------------------------------------------------------------------------------------------
RHDV-G5        ----------------------------------------------------------------------------------------------------
RHDVa-G6       ----------------------------------------------------------------------------------------------------
RCV            ----------------------------------------------------------------------------------------------------
06-11          ----------------------------------------------------------------------------------------------------
MRCV           ----------------------------------------------------------------------------------------------------
RHDV2      ----------------------------------------------------------------------------------N-----------------
RCVA-1         ---T------------------------------C-I-------E----------------------------------------------V--------
210       220       230       240 250       260       270       280       290       300
|         |         |         | |         |         |         |         |         |
RHDV-G1        PFGGSTSAIQVTVETRPSEDFEFVMIRAPSSKTVDSISPAGLLTTPVLTGVGNDNRWNGQIVGLQPVPGGFSTCNRHWNLNGSTYGWSSPRFADIDHRRG
RHDV-G2 ----------------------------------------------------------------------------------------------------
RHDV-G3/G4     ----------------------------------------------------------------------------------------------------
RHDV-G5        --------------------------------------------------------------------------------------------------S-
RHDVa-G6       ------N-----------D---------------------------------------------------------------------------------
RCV            ------------------------------------VT--------------T-----C-----------L---------------------T-------
06-11          ------------------------------------V---------------T-------------------------------------S-T-------
MRCV           ------------------------------------V---------------T-----S-------I-------------S---F-----H---------
RHDV2      ----------------------------------------D-----------T------E------------------------F--------A---D--
RCVA-1     ----T-N--------K---------V----------V---------------T---------A---------------------F-------T----P--
V1 V2 V3 V4
310       320       330       340       350       360 370       380       390       400
|         |         |         |         |         | |         |         |         |
RHDV-G1        SASYPGNNATNVLQFWYANAGSAIDNPISQVAPDGFPDMSFVPFNGPGIPAAGWVGFGAIWNSNSGAPNVTTVQAYELGFATGAPGNLQPTTNTSGSQTV
RHDV-G2 ------S-----------------------------------------------------------------------------------------A---
RHDV-G3/G4     -----------------------V------------------------------------------------------------------------A---
RHDV-G5        ------S----------------V------------------------------------------------------------------------A---
RHDVa-G6       ----S---S------------------------------------S-N--T-------G-----N---AA---------------N----------A---
RCV            .--Q--G-..-------------V----C--------------L---NV-T----------------------------------N----A-------I-
06-11          V-TR--TT..D-------S----TE----------------I-----SV--------------D------------Q-----N--N-V--------A-V-
MRCV           I-NH--G-GN-----------.TA-----------------------NV-T-------S----D-----------------------IR----S--A-I-
RHDV2      N-----SSSS---EL---S----A------I-------------S-TTV-T-------G-----N---F----------------S-P----T---A-I-
RCVA-1         ------SSG----E----QT-T-A------I---------------QNV-TG------EV---AN-T-Y-G--------------N-I--A-----A-V-
V5 E              V6 V7
410       420 430 440       450       460       470       480 490       
|         | | |         |         |         |         | |         
RHDV-G1        AKSIYAVVTGTAQNPAGLFVMASGVISTPS.ANAITYTPQPDRIVTTPGTPAAAPVGKNTPIMFASVVRRTGDVNATAGSANGTQYGTGSQPLPVTIGLS
RHDV-G2 ------------------------I----N.---------------------------------------------------------------------
RHDV-G3/G4     -----------------------------N.---------------------------------------------------------------------
RHDV-G5        -----------G------------I----N.-------------------------------------------------T-------------------
RHDVa-G6 -----------N---T-------------N.-S-V-----------------------------------------A---T-------------------
RCV            -------S--AN-----------------T.-R------------NA------------V----------------E---D-------------------
06-11          -------S--S-------------I----N.-T------------NA----------R-V------II-----I--A---S-------------------
MRCV           -------S---N--------T-A-I---QG.TS------------V---------------------------I--A---G-------------------
RHDV2      -----G-A--IN-AT--------------N.SS--------N---NA--------------------------I--E----------A--------V---
RCVA-1         -------AN-QN-GT-----L---I----NGPA-T------N---NA----------R-V-------I-----I--G-----------------------
500 510       520       530       540 550       560       570     579
| |         |         |         | |         |         |     |
RHDV-G1        LNNYSSALMPGQFFVWQLTFASGFMEIGLSVDGYFYAGTGASTTLIDLTELIDVRPVGPRPSKSTLVFNLGGTANGFSYV
RHDV-G2 --------------------------------------------------------------------------------
RHDV-G3/G4     --------------------------------------------------------------------------------
RHDV-G5        ------------------------------------------------------------------------A-------
RHDVa-G6 -------------------------------------------------------------------------T------
RCV            --------T---------N----------N-----------------------I--------T---------ATS-----
06-11          -----------------------------------------------------I--------T----------TS-----
MRCV           ---F--S----------------------------------------------I--------T----------TS-----
RHDV2      ------------------N-------L---------------A-----S--V-I--------T----Y-----T------
RCVA-1         --------T---------N-T-------------------SL------S----I--------T---------AT------
Figure 1 (See legend on next page.)
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Figure 1 Consensus amino acid sequence alignment of the VP60 gene from RHDV2 and other lagoviruses. The aligned lagovirus
sequences correspond to the consensus sequences of i) pathogenic RHDV and RHDVa sequences (47 sequences) belonging to the different
genetic groups (G1 to G6) identified by Le Gall-Reculé et al. [16], ii) RCV-A1 sequences (36 sequences). Three other rabbit lagovirus sequences
were aligned and correspond to the non-pathogenic RCV (X96868), the non-pathogenic 06–11 (AM268419) and the moderately pathogenic
MRCV (GQ166866) strains. Residues differing from the first sequence are shown and a dot corresponds to a deletion. The hypervariable regions V1
to V7 according to Wang et al. [43] are indicated at the top of the alignment. The amino acid S238 (in bold and underlined in the first sequence)
corresponds to the beginning of the protrusion domain of the VP60 protein [43]. The RHDV2 mutated amino acids shared by no other rabbit
lagovirus are highlighted in grey.
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http://www.veterinaryresearch.org/content/44/1/81identical protocol to prepare the different RHDV2 inoc-
ula, we may assume that we used about the same viral
dose for each viral infection. Thus, the difference in
mortality between the RHDV2 and RHDV-RHDVa
viruses is most likely not due to a difference in the
amount of viral particles inoculated. Most experiments
were carried out on New Zealand rabbits inoculated by
the oral route with the 10–28 or 10–32 strains (Table 2),
which enable to test a strain on the mortality rates
avoiding possible confounding factors. Statistical ana-
lyses on the pooled data for each strain showed a clear
strain effect on the observed mortality rates (χ2 = 9.72,
df = 1, p = 0.002) confirming that strain 10–28 caused a
significantly higher mortality rate (46%, n = 24) than did
strain 10–32 (9%, n = 32). The strain effect likely ex-
plains most of the observed variability in mortality rates
in our experimental trials.
A second challenge with the reference RHDV BS89
strain was carried out on 18 seropositive rabbits that
had survived an RHDV2 challenge (4 survivors of the
Ud11 challenge in study F and 14 survivors of the 10–32
challenge in studies I and L; Table 2). Three of the rab-
bits died and the presence of the challenge viral strain in
livers was confirmed. Thus, partial protection against
RHDV was induced by anti-RHDV2 antibodies.
Epidemiological study
The retrospective study carried out on RHDV isolates
collected in France since January 2009 shows that the
first occurrences of RHDV2 were detected in April 2010
in a rabbitry in western France (case 10–01) and in May
2010 in a wild rabbit in the centre of France. In wild
populations from May to December 2010, i.e. after the
virus detection, RHDV2 was responsible for 74% (25/34)
of the recorded RHD epizootics, mainly located in
north-western France (Figure 3). In 2011, RHDV2 was
responsible for 73% (29/40) of the recorded epizootics
between January and June, and for 95% (41/43) of the
recorded epizootics between July and December. It was
detected in southern France as early as February 2011,
showing the large-scale spread of the virus (Figure 3).
In domestic rabbits, RHDV2 was responsible for 93%
of the recorded epizootics between October 2010 and
December 2011 (54/58). In addition, we confirmed thedisease in recently RHDV-vaccinated rabbits (3–4 months
earlier) and the specificity of the clinical signs (subacute/
chronic forms of RHD, higher mortality rates in 4-week-
old rabbits).
In Italy, the antigenic profile of the 74 RHDV isolates
identified between November 2009 and October 2011
showed that RHDV2 was involved in only two outbreaks
that occurred in the Friuli region (Udine) in June and
July 2011. These cases were epidemiologically linked
since the rabbitries belong to the same owner. Since
these initial cases, RHDV2 has been identified in two
more regions. In Sardinia, at least 4 distinct cases were
reported in October-December 2011, in both domestic
and wild rabbits in different locations on the island
(A. Puggioni, personal communications). In the Trentino
region, an outbreak involving an open-space rural farm
and the nearby wild populations was recorded in
January-February 2012 (D. Dellamaria, personal com-
munications). Therefore, as opposed to France, most
of these RHDV cases were due to classical RHDV and
RHDVa strains, and were found mainly in small rural
units.
Discussion
In 2010, we identified in both wild and commercially
bred rabbits a pathogenic lagovirus which differs from
RHDV in terms of phylogenetic position, antigenic pro-
file and pathogenicity.
According to Kinnear and Linde [19], full-length cap-
sid protein gene sequences provide a sufficient number
of sequences and information per sequence to enable ro-
bust phylogenetic inference. Thus, the genetic relation-
ships determined in this study on the complete capsid
gene sequences confirm the results previously observed
on a 354 bp-long fragment of the VP60 gene [27] and
show that RHDV2 is phylogenetically distinct from all
previously described members of the genus Lagovirus
and forms a new genetic group. RHDV2 is less virulent
than the previous described RHDV and RHDVa strains.
In addition, the clinical characteristics of the induced
disease are rather different from those described in
“classical” RHD, notably in terms of disease duration,
mortality rates and the occurrence of subacute/chronic
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Figure 2 Phylogenetic tree derived for VP60 gene nucleotide sequences of 127 rabbit lagoviruses including 7 RHDV2. The tree was
obtained using the Neighbor-Joining method and was drawn to a scale of nucleotide substitutions per site. The percentages greater than 70% of
replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are given in italics before each major branch
node. The European brown hare syndrome virus (EBHSV) strain GD (Z69620) was used as an outgroup to root the tree. The names of some
representative strains from different countries are shown. For RHDV, the genetic groups G1 to G6 according to Le Gall-Reculé et al. [16] and clade
1 to 4, or A to D, according to Kerr et al. [18] or to Kinnear et al. [19], respectively, are annotated.
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http://www.veterinaryresearch.org/content/44/1/81conferred by commercial vaccines as well as the morta-
lity observed in convalescent RHDV2 rabbits when chal-
lenged with classical RHDV, show that cross-protection
between RHDV and RHDV2 is partial. This partial
cross-protection is consistent with the antigenic cha-
racteristics of RHDV2, which differ from RHDV and
RHDVa. All these results suggest that RHDV2 can be
considered to be a new member of the genus Lagovirus.Table 1 Antigenic characterisation of RHDV2 by ELISA
using specific MAbs for RHDV and EBHSV reference
strains.
MAb RHDV RHDVa EBHSV RHDV2
i) 2A10 100 0 0 0
1H3 100 0 0 0
1H8 100 0 0 0
ii) 3B12 0 100 0 0
3D4 0 100 0 0
3D6 0 100 0 0
5D11 0 100 0 0
2E1 0 100 0 0
iii) 2B4 100 100 0 0
2G3 100 100 0 0
1F10 100 100 0 15
6H6 100 100 0 50
3H2 100 100 0 100
6D6 100 100 100 100
2F9 100 100 100 100
3H6 100 100 100 100
iv) 2B2 0 0 100 0
1C5 0 0 100 0
3D6 0 0 100 0
4E3 0 0 100 0
1F8 0 0 100 0
5F5 0 0 100 0
1G8 0 0 100 0
1H1 0 0 100 0
1H12 0 0 100 0
4H4 0 0 100 0
On the basis of their reactivity, the 26 monoclonal antibodies (MAb) were
divided into 4 subsets. The reactivity of each MAb is given in percentage.
Thus, 100 corresponds to a reactivity of 100% whereas 0 corresponds to an
absence of reactivity.We therefore propose to name this lagovirus RHDV2 to
distinguish it from the original RHDV and RHDVa
strains and to underline its membership in a second dis-
tinct lineage of pathogenic rabbit lagoviruses.
The observed differences in virulence between RHDV
and RHDV2, and also in virulence among RHDV2, offer
new insights into poorly documented host-virus inter-
action mechanisms in lagoviruses. The differences in
pathogenicity could be related to the specificity of the
virus for histo-blood group antigens (HBGA) involved in
rabbit sensitivity to RHDV [44]. Another hypothesis is
that small genetic divergences on specific sites may be
responsible for the observed gradient of virulence be-
tween strains. The antigenic profile of RHDV2 indicates
clear differences with RHDV and RHDVa in the viral
surface where neutralizing epitopes are located. Some
substitutions in the capsid gene specific to RHDV2 may
explain these antigenic and pathogenic properties of
RHDV2. Indeed, RHDV2 shows genetic variation within
several regions of the capsid sequence that may contri-
bute to the binding specificities of HBGA and that may
be involved in RHDV antigenicity [43].
The epidemiological survey shows that the first docu-
mented cases of RHD caused by RHDV2 occurred in
France in April and May 2010 in a rabbitry and in a wild
population, respectively. This emergence remained un-
detected until the arrival of the first cases affecting vac-
cinated farmed rabbits in August 2010. RHDV2 then
quickly spread throughout France, from the north-west
to the south, and recently, after having crossed geogra-
phical barriers (the Alps and Pyrenees), also spread to
two adjacent countries: Spain (May 2011) as confirmed
by the phylogenetic analysis of two sequences available
in databases (JQ 627641 [45] and JX133161 [46]) (data
not shown), and Italy (June 2011). The rapid spread of
the new virus was quite spectacular and can be partly
explained by the imperfect protection of wild rabbits
conferred by RHDV against RHDV2. Our data also show
that RHDV2 has almost completely replaced classic
RHDV isolates in France in both wild and domestic pop-
ulations. This trend is a major concern for the rabbit in-
dustry since current commercial vaccines, which were
developed for classic RHDV, have limited efficacy against
RHDV2. The moderate virulence of RHDV2 is probably
a selective advantage and may explain its ability to re-
place highly pathogenic RHDV in wild populations in
Table 2 Mortality results following experimental challenges with 4 RHDV2 or 1 RHDV reference strains.
Study Rabbit origin Administration
route




A1 NZ IM 10-07 1/5 /
V/RHD/4 3/5 /
B1 NZ oral 10-28 6/8 /
C NZ IM 10-28 1/2 1/1
oral 10-28 2/2 /
D NZ oral 10-28 3/9 6/6
E NZ oral 10-28 0/5 5/5
F NZ oral Ud11 1/5 4/4 0/43
G1 NZ oral 10-32 0/8 /
V/RHD/4 8/8 /
H NZ oral 10-32 0/3 3/3
I NZ IV 10-32 0/4 4/4 0/13
oral 10-32 1/6 5/5 2/43
J NZ oral 10-32 2/5 3/3
K NZ oral 10-32 0/5 4(1)/5
L NZ oral 10-32 0/5 5/5 0/43
Rural oral 10-32 0/5 5/5 1/5
The experimental challenges were performed with RHDV2 strains 10–07, 10–28, 10–32, and Ud11, or with the French RHDV reference strain V/RHD/4, using
different inoculation routes. For experiments F, I, and L, mortality results following a second challenge with the Italian RHDV reference strain BS89 of the survivor
rabbits are shown.
NZ New Zealand, IM intramuscularly route, IV intravenous route.
1no serological data.
2doubtful because just above the threshold.
3the 2nd challenge was performed on a part of the survivor rabbits.
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http://www.veterinaryresearch.org/content/44/1/81France. This observation had been predicted by Fouchet
et al. [47] using a model system which showed that
moderately virulent RHDV-related strains invaded frag-
mented rabbit populations such as wild rabbit popu-
lations, with greater efficacy than highly virulent or
non-pathogenic strains.
On the contrary to what happened in France, RHDV2
did not spread within continental Italy. Few cases of
RHDV2 were reported between mid 2011 and early
2012, and most RHD outbreaks were caused by classicalMay-December 2010 January-June 2011
Figure 3 Spatial distribution of RHD outbreaks in wild rabbit populat
The color indicates the RHDV strains involved in these outbreaks. Light blu
white: no data. Red star: first detected outbreak of RHDV2 in a rabbitry (Ap
(May 2010).RHDV or RHDVa strains, mainly in small rural units. As
a consequence the replacement of circulating RHDV or
RHDVa isolates has not been observed. On the contrary
in Sardinia, the observations were similar to those made
in France since the rapid spread of RHDV2 was re-
ported, with several cases detected in a very short period
of time throughout the island. In most parts of France as
in Sardinia, wild rabbits are widespread and present
throughout the entire country, whereas in continental
Italy wild rabbit populations are sparse and patchilyJuly-December 2011
ions in France in 2010 and 2011. Data are pooled by département.
e: classic RHDV; dark blue: RHDV2; squared: classic RHDV and RHDV2;
ril 2010); white star: first detected case of RHDV2 in a wild population
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exert strong selection pressure on the virus since the se-
lective advantage of RHDV2 is only expressed where
wild populations of rabbits are present.
The long distance between successive recorded cases
from northern Italy to Sardinia, and also in France be-
tween the first detected case in a rabbitry in North-
Western France and the second one in a wild population
in central France, poses some epidemiological issues re-
garding the sources and routes of spread of the virus.
The diffusion of the virus does not seem to be linked
only to commercial trade since after the Udine outbreak
no secondary outbreaks were detected in Italian indus-
trial farms. An exhaustive epidemiological survey would
be necessary to explain these different observations.
The emergence of RHDV2 raises the question of the ori-
gin of this new lagovirus. The molecular epidemiological
investigations carried out regularly in France since the
emergence of RHDV [14,48] and the last one performed
on samples collected in 2008 (G. Le Gall-Reculé, unpub-
lished data), did not detect the arrival of such a genetic
shift. The two possible causes of emergence of RHDV2 are
either the evolution of a pre-existing non-pathogenic virus
or a species jump from a reservoir host species. Molecular
data show that RHDV2 did not emerge following genetic
evolution among previously known lagoviruses. Indeed,
when comparing RHDV2 to other lagoviruses, the amino
acid substitutions are distributed throughout the VP60
gene and several of them are not shared by any other
known rabbit lagovirus. The emergence of RHDV2 from a
non-pathogenic lagovirus has not been proven yet, but this
hypothesis cannot be definitively excluded since knowledge
of non-pathogenic lagoviruses remains scarce. However, a
recent study based on the analysis of complete capsid gene
sequences estimated an accurate evolution rate in RHDV
after removing one misdated RHDV from the databases
[49]. This evolution rate is higher than those previously es-
timated [18,19,50]. Using it, the emergence of virulence is
estimated to have taken place early in the 20th century, in
1918 (95% CI: 1893–1941), i.e. well before the first occur-
rence of the disease in 1984. It is unlikely that such a highly
pathogenic virus could have gone undetected over such a
long period in a species of economic interest. Therefore,
the alternative hypothesis of a species jump could be put
forth to explain the emergence of RHDV, with the evolu-
tion towards virulence having occurred in a species other
than the rabbit of genus Oryctolagus. According to this hy-
pothesis, the emergence of RHDV2 could be due to a sec-
ond lagovirus species jump from a putative original host to
the rabbit, the first one being the emergence of RHDV in
the 1980s. The discovery of this reservoir host species
would give weight to this hypothesis and could facilitate
understanding of the emergence of pathogenic lagoviruses
in rabbits and perhaps also in hares.Additional file
Additional file 1: Rabbit lagovirus VP60 sequences used for the
phylogenetic analyses. Sequences are ordered according to their
position in the phylogenetic tree (Figure 2). The virus name corresponds
to the country of origin, the name of the isolate and the year of
collection (when known). For RHDV, the genetic groups are annotated
according to Le Gall-Reculé et al. [16] / Kerr et al. [17] / Kinnear et al. [19].
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